Register entry
Merck Sharp & Dohme Corp.
- Registered sites
- 0
- Drug products
- 121
- Live patents
- 144
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
144Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| BELSOMRA | SUVOREXANT | Nov 2029 |
| BELSOMRA | SUVOREXANT | May 2033 |
| DELSTRIGO | DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | Aug 2032 |
| DELSTRIGO | DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | Nov 2036 |
| DUTREBIS | LAMIVUDINE; RALTEGRAVIR POTASSIUM | Mar 2029 |
| DUTREBIS | LAMIVUDINE; RALTEGRAVIR POTASSIUM | Sept 2029 |
| EMEND | APREPITANT | Sept 2027 |
| IDVYNSO | DORAVIRINE; ISLATRAVIR | May 2027 |
| IDVYNSO | DORAVIRINE; ISLATRAVIR | Aug 2032 |
| ISENTRESS | RALTEGRAVIR POTASSIUM | Jan 2028 |
| ISENTRESS | RALTEGRAVIR POTASSIUM | Mar 2029 |
| ISENTRESS | RALTEGRAVIR POTASSIUM | Sept 2029 |
| ISENTRESS | RALTEGRAVIR POTASSIUM | Jun 2030 |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | Mar 2029 |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | Sept 2029 |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | Jun 2030 |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | Oct 2030 |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | Apr 2031 |
| ISENTRESS HD | RALTEGRAVIR POTASSIUM | Mar 2032 |
| JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | Nov 2026 |
| JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | May 2027 |
| JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | Jul 2028 |
| JANUMET | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | Jan 2029 |
| JANUMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | Nov 2026 |
| JANUMET XR | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | May 2027 |
| JANUVIA | SITAGLIPTIN PHOSPHATE | Nov 2026 |
| JANUVIA | SITAGLIPTIN PHOSPHATE | May 2027 |
| JUVISYNC | SIMVASTATIN; SITAGLIPTIN PHOSPHATE | Oct 2026 |
| LIPFENDRA | ENLICITIDE DECANOATE | Feb 2040 |
| NOXAFIL | POSACONAZOLE | Mar 2029 |
| NOXAFIL | POSACONAZOLE | Jun 2031 |
| NOXAFIL | POSACONAZOLE | Jul 2031 |
| NOXAFIL | POSACONAZOLE | Feb 2033 |
| OHTUVAYRE | ENSIFENTRINE | Aug 2031 |
| OHTUVAYRE | ENSIFENTRINE | Sept 2035 |
| OHTUVAYRE | ENSIFENTRINE | Feb 2043 |
| OHTUVAYRE | ENSIFENTRINE | Jun 2044 |
| PIFELTRO | DORAVIRINE | Aug 2032 |
| PREVYMIS | LETERMOVIR | Jan 2029 |
| PREVYMIS | LETERMOVIR | Feb 2033 |
| RECARBRIO | CILASTATIN SODIUM; IMIPENEM; RELEBACTAM | Mar 2033 |
| SEGLUROMET | ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE | Oct 2030 |
| SEGLUROMET | ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE | Dec 2031 |
| STEGLATRO | ERTUGLIFLOZIN | Dec 2031 |
| STEGLUJAN | ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE | Nov 2026 |
| STEGLUJAN | ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE | May 2027 |
| STEGLUJAN | ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE | Oct 2030 |
| STEGLUJAN | ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE | Dec 2031 |
| VERQUVO | VERICIGUAT | May 2031 |
| VERQUVO | VERICIGUAT | Nov 2032 |
| VICTRELIS | BOCEPREVIR | Mar 2027 |
| VICTRELIS | BOCEPREVIR | Nov 2027 |
| WELIREG | BELZUTIFAN | Sept 2034 |
| WELIREG | BELZUTIFAN | Apr 2036 |
| WELIREG | BELZUTIFAN | Jun 2042 |
| ZEPATIER | ELBASVIR; GRAZOPREVIR | Jul 2029 |
| ZEPATIER | ELBASVIR; GRAZOPREVIR | May 2031 |
| ZOLINZA | VORINOSTAT | Mar 2027 |
| ZOLINZA | VORINOSTAT | Mar 2028 |
Catalogue
Marketed products
121Showing 121 of 121.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| ANTIVENIN | Latrodectus mactans | KIT | BLA |
| BCG VACCINE | BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | BLA |
| BELSOMRA | suvorexant | TABLET, FILM COATED | NDA |
| BELSOMRA | suvorexant | TABLET, FILM COATED | NDA |
| BELSOMRA | suvorexant | TABLET, FILM COATED | NDA |
| BELSOMRA | suvorexant | TABLET, FILM COATED | NDA |
| BRIDION | sugammadex | INJECTION, SOLUTION | NDA |
| BRIDION | sugammadex | INJECTION, SOLUTION | NDA |
| CANCIDAS | CASPOFUNGIN ACETATE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| CANCIDAS | CASPOFUNGIN ACETATE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| CAPVAXIVE | Pneumococcal 21-valent Conjugate Vaccine | INJECTION, SOLUTION | BLA |
| - | CASPOFUNGIN ACETATE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | EXPORT ONLY |
| - | CILASTATIN SODIUM | POWDER | EXPORT ONLY |
| DELSTRIGO | doravirine, lamivudine, and tenofovir disoproxil fumarate | TABLET, FILM COATED | NDA |
| DIFICID | FIDAXOMICIN | GRANULE, FOR SUSPENSION | NDA |
| Dificid | fidaxomicin | TABLET, FILM COATED | NDA |
| EMEND | aprepitant | CAPSULE | NDA |
| EMEND | aprepitant | CAPSULE | NDA |
| EMEND | aprepitant | CAPSULE | NDA |
| EMEND | FOSAPREPITANT DIMEGLUMINE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| EMEND | aprepitant | POWDER, FOR SUSPENSION | NDA |
| EMEND | aprepitant | KIT | NDA |
| ENFLONSIA | CLESROVIMAB | INJECTION, SOLUTION | BLA |
| ERVEBO | ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN | INJECTION, SOLUTION | BLA |
| - | Ertapenem Sodium | POWDER | EXPORT ONLY |
| GARDASIL | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant | INJECTION, SUSPENSION | BLA |
| GARDASIL | Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant | INJECTION, SUSPENSION | BLA |
| GARDASIL 9 | Human Papillomavirus 9-valent Vaccine, Recombinant | INJECTION, SUSPENSION | BLA |
| GARDASIL 9 | Human Papillomavirus 9-valent Vaccine, Recombinant | INJECTION, SUSPENSION | BLA |
| - | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN | LIQUID | EXPORT ONLY |
| - | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN | LIQUID | EXPORT ONLY |
| IDVYNSO | Doravirine, Islatravir | TABLET, FILM COATED | NDA |
| - | IMIPENEM | POWDER | EXPORT ONLY |
| - | IMIPENEM ANHYDROUS, cilastatin, and RELEBACTAM ANHYDROUS | INJECTION, POWDER, FOR SOLUTION | DRUG FOR FURTHER PROCESSING |
| INVANZ | ertapenem sodium | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| ISENTRESS | RALTEGRAVIR | TABLET, FILM COATED | NDA |
| ISENTRESS | RALTEGRAVIR | TABLET, CHEWABLE | NDA |
| ISENTRESS | RALTEGRAVIR | TABLET, CHEWABLE | NDA |
| ISENTRESS | RALTEGRAVIR | TABLET, FILM COATED | NDA |
| ISENTRESS | RALTEGRAVIR | GRANULE, FOR SUSPENSION | NDA |
| JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | TABLET, FILM COATED | NDA |
| JANUMET | SITAGLIPTIN and METFORMIN HYDROCHLORIDE | TABLET, FILM COATED | NDA |
| JANUMET XR | sitagliptin and metformin hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| JANUMET XR | sitagliptin and metformin hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| JANUMET XR | sitagliptin and metformin hydrochloride | TABLET, FILM COATED, EXTENDED RELEASE | NDA |
| JANUVIA | sitagliptin | TABLET, FILM COATED | NDA |
| JANUVIA | sitagliptin | TABLET, FILM COATED | NDA |
| JANUVIA | sitagliptin | TABLET, FILM COATED | NDA |
| KEYTRUDA | pembrolizumab | INJECTION, SOLUTION | BLA |
| KEYTRUDA QLEX | pembrolizumab and berahyaluronidase alfa-pmph | INJECTION, SOLUTION | BLA |
| KEYTRUDA QLEX | pembrolizumab and berahyaluronidase alfa-pmph | INJECTION, SOLUTION | BLA |
| LIPFENDRA | LIPFENDRA | TABLET, FILM COATED | NDA |
| M-M-R II | measles, mumps, and rubella virus vaccine live | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | BLA |
| NOXAFIL | posaconazole | SUSPENSION | NDA |
| NOXAFIL | posaconazole | POWDER, FOR SUSPENSION | NDA |
| NOXAFIL | posaconazole | TABLET, COATED | NDA |
| NOXAFIL | posaconazole | SOLUTION | NDA |
| Ohtuvayre | ensifentrine | SUSPENSION | NDA |
| PIFELTRO | doravirine | TABLET, FILM COATED | NDA |
| PNEUMOVAX 23 | pneumococcal vaccine polyvalent | INJECTION, SOLUTION | BLA |
| PNEUMOVAX 23 | pneumococcal vaccine polyvalent | INJECTION, SOLUTION | BLA |
| PREVYMIS | LETERMOVIR | TABLET, FILM COATED | NDA |
| PREVYMIS | LETERMOVIR | TABLET, FILM COATED | NDA |
| PREVYMIS | LETERMOVIR | INJECTION, SOLUTION | NDA |
| PREVYMIS | LETERMOVIR | INJECTION, SOLUTION | NDA |
| PREVYMIS | LETERMOVIR | PELLET | NDA |
| PREVYMIS | LETERMOVIR | PELLET | NDA |
| PRIMAXIN IV | imipenem and cilastatin sodium | INJECTION, POWDER, FOR SOLUTION | NDA |
| PedvaxHIB | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) | INJECTION, SUSPENSION | BLA |
| ProQuad | Measles, Mumps, Rubella and Varicella Virus Vaccine Live | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | BLA |
| RECARBRIO | imipenem anhydrous, cilastatin, and relebactam anhydrous | INJECTION, POWDER, FOR SOLUTION | NDA |
| RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | INJECTION, SUSPENSION | BLA |
| RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | INJECTION, SUSPENSION | BLA |
| RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | INJECTION, SUSPENSION | BLA |
| RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | INJECTION, SUSPENSION | BLA |
| RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) | INJECTION, SUSPENSION | BLA |
| RotaTeq | Rotavirus Vaccine, Live, Oral, Pentavalent | SOLUTION | BLA |
| RotaTeq | Rotavirus Vaccine, Live, Oral, Pentavalent | SOLUTION | BLA |
| SEGLUROMET | ertugliflozin and metformin hydrochloride | TABLET, FILM COATED | NDA |
| SEGLUROMET | ertugliflozin and metformin hydrochloride | TABLET, FILM COATED | NDA |
| SEGLUROMET | ertugliflozin and metformin hydrochloride | TABLET, FILM COATED | NDA |
| SEGLUROMET | ertugliflozin and metformin hydrochloride | TABLET, FILM COATED | NDA |
| SIVEXTRO | tedizolid phosphate | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| SIVEXTRO | tedizolid phosphate | TABLET, FILM COATED | NDA |
| STEGLATRO | ertugliflozin | TABLET, FILM COATED | NDA |
| STEGLATRO | ertugliflozin | TABLET, FILM COATED | NDA |
| STEGLUJAN | ertugliflozin and sitagliptin | TABLET, FILM COATED | NDA |
| STEGLUJAN | ertugliflozin and sitagliptin | TABLET, FILM COATED | NDA |
| STERILE DILUENT | Sterile Water | INJECTION | BLA |
| STERILE DILUENT | Sterile Water | INJECTION | BLA |
| STROMECTOL | ivermectin | TABLET | NDA |
| TEMODAR | Temozolomide | CAPSULE | NDA |
| TEMODAR | Temozolomide | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| TEMODAR | Temozolomide | CAPSULE | NDA |
| TEMODAR | Temozolomide | CAPSULE | NDA |
| TEMODAR | Temozolomide | CAPSULE | NDA |
| TEMODAR | Temozolomide | CAPSULE | NDA |
| TEMODAR | Temozolomide | CAPSULE | NDA |
| TICE BCG | BACILLUS CALMETTE-GUERIN | POWDER, FOR SUSPENSION | BLA |
| VAQTA | hepatitis A vaccine, inactivated | INJECTION, SUSPENSION | BLA |
| VAQTA | hepatitis A vaccine, inactivated | INJECTION, SUSPENSION | BLA |
| VAQTA | hepatitis A vaccine, inactivated | INJECTION, SUSPENSION | BLA |
| VAQTA | hepatitis A vaccine, inactivated | INJECTION, SUSPENSION | BLA |
| VARIVAX | Varicella Virus Vaccine Live | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | BLA |
| VAXNEUVANCE | Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed | INJECTION, SUSPENSION | BLA |
| VERQUVO | vericiguat | TABLET, FILM COATED | NDA |
| VERQUVO | vericiguat | TABLET, FILM COATED | NDA |
| VERQUVO | vericiguat | TABLET, FILM COATED | NDA |
| WELIREG | belzutifan | TABLET, FILM COATED | NDA |
| WINREVAIR | SOTATERCEPT-CSRK | KIT | BLA |
| WINREVAIR | SOTATERCEPT-CSRK | KIT | BLA |
| WINREVAIR | SOTATERCEPT-CSRK | KIT | BLA |
| WINREVAIR | SOTATERCEPT-CSRK | KIT | BLA |
| ZEPATIER | elbasvir and grazoprevir | TABLET, FILM COATED | NDA |
| ZERBAXA | ceftolozane and tazobactam | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| ZINPLAVA | bezlotoxumab | INJECTION, SOLUTION | BLA |
| ZOLINZA | vorinostat | CAPSULE | NDA |
| - | suvorexant | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | suvorexant | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | suvorexant | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | suvorexant | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.